You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 168 No. 20, November 10, 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Patient Education/ Health Literacy
 •Cardiovascular System
 •Rehabilitation Medicine
 •Randomized Controlled Trial
 •Cardiovascular Disease/ Myocardial Infarction
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Global Secondary Prevention Strategies to Limit Event Recurrence After Myocardial Infarction

Results of the GOSPEL Study, a Multicenter, Randomized Controlled Trial From the Italian Cardiac Rehabilitation Network

Pantaleo Giannuzzi, MD; Pier Luigi Temporelli, MD; Roberto Marchioli, MD; Aldo Pietro Maggioni, MD; Gianluigi Balestroni, PhD; Vincenzo Ceci, MD; Carmine Chieffo, MD; Marinella Gattone, MD; Raffaele Griffo, MD; Carlo Schweiger, MD; Luigi Tavazzi, MD; Stefano Urbinati, MD; Franco Valagussa, MD{dagger}; Diego Vanuzzo, MD; for the GOSPEL Investigators

Arch Intern Med. 2008;168(20):2194-2204.

Background  Secondary prevention is not adequately implemented after myocardial infarction (MI). We assessed the effect on quality of care and prognosis of a long-term, relatively intensive rehabilitation strategy after MI.

Methods  We conducted a multicenter, randomized controlled trial in patients following standard post-MI cardiac rehabilitation, comparing a long-term, reinforced, multifactorial educational and behavioral intervention with usual care. A total of 3241 patients with recent MI were randomized to a 3-year multifactorial continued educational and behavioral program (intervention group; n = 1620) or usual care (control group; n = 1621). The combination of cardiovascular (CV) mortality, nonfatal MI, nonfatal stroke, and hospitalization for angina pectoris, heart failure, or urgent revascularization procedure was the primary end point. Other end points were major CV events, major cardiac and cerebrovascular events, lifestyle habits, and drug prescriptions.

Results  End point events occurred in 556 patients (17.2%). Compared with usual care, the intensive intervention did not decrease the primary end point significantly (16.1% vs 18.2%; hazard ratio [HR], 0.88; 95% confidence interval [CI], 0.74-1.04). However, the intensive intervention decreased several secondary end points: CV mortality plus nonfatal MI and stroke (3.2% vs 4.8%; HR, 0.67; 95% CI, 0.47-0.95), cardiac death plus nonfatal myocardial infarction (2.5% vs 4.0%; HR, 0.64; 95% CI, 0.43-0.94), and nonfatal MI (1.4% vs 2.7%; HR, 0.52; 95% CI, 0.31-0.86). A marked improvement in lifestyle habits (ie, exercise, diet, psychosocial stress, less deterioration of body weight control) and in prescription of drugs for secondary prevention was seen in the intervention group.

Conclusion  The GOSPEL Study is the first trial to our knowledge to demonstrate that a multifactorial, continued reinforced intervention up to 3 years after rehabilitation following MI is effective in decreasing the risk of several important CV outcomes, particularly nonfatal MI, although the overall effect is small.

Trial Registration  ClinicalTrials.gov Identifier: NCT00421876



Author Affiliations: Fondazione Salvatore Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Veruno, Italy (Drs Giannuzzi, Temporelli, Balestroni, and Gattone); Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy (Dr Marchioli); Centro Studi Associazione Nazionale Medici Cardiologi Ospedalieri, Firenze, Italy (Dr Maggioni); Ospedale Santo Spirito, Roma, Italy (Dr Ceci); Azienda Ospedaliera San Sebastiano, Caserta, Italy (Dr Chieffo); Ospedale La Colletta, Arenzano, Italy (Dr Griffo); Azienda Ospedaliera G. Salvini, Rho-Passirana, Italy (Dr Schweiger); Fondazione IRCCS Policlinico San Matteo, Pavia, Italy (Dr Tavazzi); Ospedale Bellaria, Bologna, Italy (Dr Urbinati); Ospedale S. Gerardo, Monza, Italy (Dr Valagussa); and Centro per la Prevenzione Cardiovascolare, Udine, Italy (Dr Vanuzzo).
{dagger}Died December 1, 2006.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The year in atherothrombosis.
Sanz et al.
J Am Coll Cardiol 2009;53:1326-1337.
FULL TEXT  

CHAPTER 25 Cardiac Rehabilitation
Gielen et al.
ESC Textbook of Cardiovascular Medicine 2009;2:med-9780199566990-chapter-med-9780199566990-chapter.
ABSTRACT | FULL TEXT  

All you need to read in the other general journals
BMJ 2008;337:a2571-a2571.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.